Pre-treated Mesenchymal Stem Cell-Derived Exosomes: A New Perspective for Accelerating Spinal Cord Injury Repair
European Journal of Pharmacology,
Год журнала:
2025,
Номер
992, С. 177349 - 177349
Опубликована: Фев. 5, 2025
Spinal
cord
injury
(SCI)
is
a
devastating
event
for
the
central
nervous
system
(CNS),
often
resulting
in
loss
of
sensory
and
motor
functions.
It
profoundly
affects
both
physiological
psychological
well-being
patients,
reducing
their
quality
life
while
also
imposing
significant
economic
pressure
on
families
healthcare
system.
Due
to
complex
pathophysiology
SCI,
effective
treatments
promoting
recovery
remain
scarce.
Mesenchymal
stem
cell-derived
exosomes
(MSC-Exos)
offer
advantages
such
as
low
immunogenicity,
good
biocompatibility,
ability
cross
blood-spinal
barrier
(BSCB).
In
preclinical
studies,
they
have
progressively
shown
efficacy
SCI
repair
functional
recovery.
However,
yield
insufficient
targeting
MSC-Exos
limit
therapeutic
efficacy.
Currently,
genetic
engineering
other
preprocessing
techniques
are
being
employed
optimize
properties
exosomes,
thereby
enhancing
potential.
Therefore,
this
paper
provides
an
overview
biogenesis
exosomes.
summarizes
current
approaches
optimizing
exosome
performance.
Additionally,
it
details
mechanisms
through
which
optimized
provide
neuroprotection
explores
potential
combined
involving
hydrogels.
Язык: Английский
PTGS2 Silencing Inhibits Ferroptosis in Staphylococcus Aureus-induced Osteomyelitis By Blocking the IL-17A Signaling Pathway
Inflammation,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 21, 2025
Osteomyelitis
caused
by
Staphylococcus
aureus
(S.
aureus)
infection
is
an
inflammatory
bone
disease
characterized
continuous
destruction,
which
difficult
to
treat.
This
research
aimed
explore
the
molecular
mechanisms
of
S.
aureus-induced
osteomyelitis.
Using
GSE166522
and
GSE227521
datasets,
hub
differentially
expressed
genes
(DEGs)
were
screened
bioinformatics
analysis.
Hub
gene
expression
levels
validated
in
mouse
models.
An
inhibitor
PTGS2,
etoricoxib,
was
used
assess
role
PTGS2
osteomyelitis
model.
silenced
LPS-induced
MC3T3-E1
cell
model
study
its
effect
on
function.
Six
screened,
including
ARG1,
TIMP1,
NOS2,
SOCS3,
IL1B,
highly
Etoricoxib
treatment
attenuated
infiltration
tibial
tissue
mice
with
In
vivo
vitro,
etoricoxib
silencing
reduced
factor
(TNF-α,
IL-1β,
IL-6)
levels.
promoted
viability
inhibited
apoptosis
ferroptosis.
GPX4
SLC7A11
protein
significantly
increased
after
silencing.
Mechanistically,
IL-17A
intervention
counteracted
impact
behaviors
secukinumab
combined
more
effectively
suppressed
inflammation
ferroptosis,
indicating
that
impeded
progression
inhibiting
pathway.
Silencing
reduces
ferroptosis
obstructing
pathway,
suggests
a
new
approach
for
Язык: Английский
Repair of spinal cord injury by bone marrow mesenchymal stem cell-derived exosomes: a systematic review and meta-analysis based on rat models
Frontiers in Molecular Neuroscience,
Год журнала:
2024,
Номер
17
Опубликована: Авг. 7, 2024
Objective
This
study
aims
to
systematically
evaluate
the
efficacy
of
bone
marrow
mesenchymal
stem
cell-derived
exosomes
(BMSCs-Exo)
in
improving
spinal
cord
injury
(SCI)
mitigate
risk
translational
discrepancies
from
animal
experiments
clinical
applications.
Methods
We
conducted
a
comprehensive
literature
search
up
March
2024
using
PubMed,
Embase,
Web
Science,
and
Scopus
databases.
Two
researchers
independently
screened
literature,
extracted
data,
assessed
quality
studies.
Data
analysis
was
performed
STATA16
software.
Results
A
total
30
studies
were
included.
The
results
indicated
that
BMSCs-Exo
significantly
improved
BBB
score
SCI
rats
(WMD
=
3.47,
95%
CI
[3.31,
3.63]),
inhibited
expression
pro-inflammatory
cytokine
TNF-
α
(SMD
-3.12,
[−3.57,
−2.67]),
promoted
anti-inflammatory
cytokines
IL-10
2.76,
[1.88,
3.63])
TGF-
β
3.89,
[3.02,
4.76]).
Additionally,
reduced
apoptosis
levels
−4.52,
[−5.14,
−3.89]),
axonal
regeneration
markers
NeuN
cells/field
3.54,
[2.65,
4.42]),
NF200
4.88,
[3.70,
6.05]),
number
Nissl
bodies
1.89,
[1.13,
2.65]),
decreased
astrogliosis
marker
GFAP
−5.15,
[−6.47,
−3.82]).
heterogeneity
among
primarily
due
variations
transplantation
doses,
with
increasing
higher
doses.
Conclusion
motor
function
by
modulating
inflammatory
responses,
reducing
apoptosis,
inhibiting
astrogliosis,
promoting
regeneration.
However,
presence
selection,
performance,
detection
biases
current
may
undermine
evidence
this
study.
Язык: Английский